<DOC>
	<DOCNO>NCT00767481</DOCNO>
	<brief_summary>Parallel , Multi-Center , Double-masked , Active control , three arm study compare IOP lower efficacy safety 12 month morning even instillation Travoprost/Brinzolamide vs. Cosopt dose morning evening patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>IOP screen visit &lt; 18mmHg least one eye Mean IOP eye ( eligibility 1 &amp; 2 visit ) 24 ≤ 36 mmHg 9:00 21 ≤ 36 mmHg 11:00 16:00 Severe central visual field loss Angle Shaffer grade &lt; 2 C/D ratio &gt; 0.8 ( horizontal vertical measurement )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>Patients open-angle glaucoma ocular hypertension</keyword>
</DOC>